OBJECTIVE: This study explored both the individual and combined effects of serum tumor necrosis factor-alpha (sTNF-α) levels and employment status on suicidal behavior (SB) in patients with depressive disorders undergoing pharmacologic treatment. METHODS: Baseline measurements of sTNF-α levels were taken, and employment status was determined. Over a 1-year period of stepwise pharmacotherapy, SB was monitored and categorized into increased suicidal severity and fatal/non-fatal suicide attempts. Logistic regression models adjusted for relevant covariates were used to analyze the individual and interactive associations between sTNF-α levels, employment status, and these two forms of SB. RESULTS: Unemployment was significantly associated with both forms of SB, whereas sTNF-α levels alone did not show a significant correlation. However, lower sTNF-α levels combined with employment were associated with the lowest incidence rates of both SB categories, demonstrating significant interactive effects after adjustment. CONCLUSION: The study demonstrates that the prospective associations of sTNF-α levels for SB is enhanced when combined with employment status in patients receiving pharmacological treatment for depressive disorders. These findings suggest that integrating biological markers with socio-economic factors can improve the assessment and management of suicide risk.
Prospective Associations of Serum Tumor Necrosis Factor-Alpha and Employment on Suicidal Behaviors Over 1 Year in Depressive Patients Receiving Psychopharmacotherapy.
血清肿瘤坏死因子-α和就业与接受精神药物治疗的抑郁症患者1年内自杀行为的前瞻性关联
阅读:8
作者:Kim Ha-Yeon, Kim Ju-Wan, Kang Hee-Ju, Lee Ju-Yeon, Kim Sung-Wan, Shin Il-Seon, Chun Byung Jo, Kim Min-Gon, Kim Jae-Min
| 期刊: | Psychiatry Investigation | 影响因子: | 1.800 |
| 时间: | 2025 | 起止号: | 2025 Jul;22(7):748-756 |
| doi: | 10.30773/pi.2025.0044 | 研究方向: | 肿瘤 |
| 疾病类型: | 抑郁症 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
